FundedIQ
Biotechnology

Evergreen: Funding, Investors & Team (Sep 2026)

Evergreen is a game-changing solution to the environmental, health, and animal welfare challenges posed by animal agriculture. They offer real meat grown from cells outside the animal that's every bit as delicious and nourishing as business-as-usual meat, but no sacrifice is required.

evergreen.food LinkedIn Los Angeles, United States 11-50 employees
Alternative Protein Biotechnology Food and Beverage Food Processing B2B
Total raised
$6.0M
Rounds
1
Latest
Series A
Feb 2026

Evergreen has raised $6.0M across 1 funding round on record, the most recent a Series A of $6.0M announced in Feb 2026.

That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Evergreen Company Profile and Key Stats

Total funding raised
$6.0M
across 1 round on record
Funding rounds on record
1
Latest funding round
Series A
$6.0M in Feb 2026
Employees
11-50
reported band
Headquarters
Los Angeles, United States

Latest funding round on record: Feb 2026.

Evergreen Funding Rounds

Date
Round
Amount
Series A
$6.0M

Evergreen Founders and Leadership Team

Name
Role
Contact
Ali Khademhosseini
Founder

No contact details are on record for this team yet.

Evergreen Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,182
$8.0M
29,795
$7.5M
8,378
$15M

Evergreen's latest round of $6.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Evergreen in Biotechnology and Los Angeles

Companies Similar to Evergreen

Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…

Series B $65.5M

Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…

Seed $7.0M

ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…

Series C $10.0M

EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…

Series A $35.0M

Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…

Convertible Note $3.5M

Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…

Convertible Note $6.8M

XiltriX North America is an information technology company that specializes in monitoring, predictive…

Undisclosed round $3.0M

Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…

Seed $3.1M

Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…

Series D $66.0M

Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…

Series B $92.7M

Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…

Series C $110M

InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…

Series B $77.0M

Evergreen Funding FAQs

What does Evergreen do?

Evergreen is a game-changing solution to the environmental, health, and animal welfare challenges posed by animal agriculture. They offer real meat grown from cells outside the animal that's every bit as delicious and nourishing as business-as-usual meat, but no sacrifice is required.

How much funding has Evergreen raised?

Evergreen has raised $6.0M across 1 round on record. The most recent is a Series A of $6.0M announced in Feb 2026.

When did Evergreen last raise funding?

Evergreen's most recent funding round on record is a Series A of $6.0M, announced in Feb 2026.

Who founded Evergreen?

FundedIQ lists Ali Khademhosseini (Founder) at Evergreen.

Where is Evergreen headquartered?

Evergreen is based in Los Angeles, California, United States.

How many employees does Evergreen have?

Evergreen is in the 11-50 employee band.

How does Evergreen's funding compare to other Biotechnology startups?

Evergreen's latest round of $6.0M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.

About FundedIQ's Evergreen Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Evergreen is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.